James M. Gold

Affiliations: 
University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Neuropsychology, Schizophrenia
Google:
"James Gold"
Mean distance: 14.54 (cluster 23)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kwashie AN, Ma Y, Barch DM, et al. (2022) Comparing the functional neuroanatomy of proactive and reactive control between patients with schizophrenia and healthy controls. Cognitive, Affective & Behavioral Neuroscience
Erickson MA, Lopez-Calderon J, Robinson B, et al. (2022) Gamma-band entrainment abnormalities in schizophrenia: Modality-specific or cortex-wide impairment? Journal of Psychopathology and Clinical Science. 131: 895-905
Barch DM, Boudewyn MA, Carter CC, et al. (2022) Cognitive [Computational] Neuroscience Test Reliability and Clinical Applications for Serious Mental Illness (CNTRaCS) Consortium: Progress and Future Directions. Current Topics in Behavioral Neurosciences
Gold JM, Luck SJ. (2022) Working Memory in People with Schizophrenia. Current Topics in Behavioral Neurosciences
Luck SJ, Gold JM. (2022) Attention in Schizophrenia. Current Topics in Behavioral Neurosciences
Millman ZB, Schiffman J, Gold JM, et al. (2022) Linking Salience Signaling With Early Adversity and Affective Distress in Individuals at Clinical High Risk for Psychosis: Results From an Event-Related fMRI Study. Schizophrenia Bulletin Open. 3: sgac039
Catalano LT, Wynn JK, Green MF, et al. (2022) Reduced neural activity when anticipating social versus nonsocial rewards in schizophrenia: Preliminary evidence from an ERP study. Schizophrenia Research. 246: 7-16
Williams TF, Powers AR, Ellman LM, et al. (2022) Three prominent self-report risk measures show unique and overlapping utility in characterizing those at clinical high-risk for psychosis. Schizophrenia Research. 244: 58-65
Spilka MJ, Keller WR, Buchanan RW, et al. (2022) Endogenous oxytocin levels are associated with facial emotion recognition accuracy but not gaze behavior in individuals with schizophrenia. Acta Psychiatrica Scandinavica
Culbreth AJ, Kasanova Z, Ross TJ, et al. (2021) Schizophrenia Patients Show Largely Similar Salience Signaling Compared to Healthy Controls in an Observational Task Environment. Brain Sciences. 11
See more...